Monoethanolamine

 

Medium Hazard Concern

Facts about this ingredient

  • Monoethanolamine is suspected of causing endocrine-disrupting effects, according to European Commission Annex 13. Includes both Category 1 (evidence for endocrine disruption in living organisms) and Category 2 (evidence of potential to cause endocrine disruption in in vitro studies)
  • Monoethanolamine is suspected of causing gastrointestinal orlLiver Toxicity Hazards, according to various official national and international hazard classification systems and/or by being recognized under EPA - IRIS Inhalation Reference Concentration (RfC) list and/or EPA - IRIS Oral Reference Dose (RfD) as having appropriate critical effects.
  • Monoethanolamine is suspected of causing asthma. This list is a compilation of various sources including those that "may cause sensitization by inhalation" and includes some agents that are identified according to the Association of Occupational and Environmental Clinics (AOEC) as asthmagens or chemicals of concern for their potential to cause asthma.
  • Monoethanolamine is a suspected neurotoxin.
  • Monoethanolamine is suspected of causing neurotoxicity, according to various official national and internation hazard classification systems and/or by being recognized under EPA - IRIS Inhalation Reference Concentration (RfC) list and/or EPA - IRIS Oral Reference Dose (RfD) as having appropriate critical effects.
  • It is not on any of GoodGuide’s lists of toxic chemicals which cause suspected or recognized health effects. It has not been detected in human tissue or urine.

Products with this ingredient

View all products

Found in